Brocklebank A M, Sparrow R L
Development Unit, Australian Red Cross Blood Service-Victoria, Southbank, South Melbourne, Victoria 3205, Australia.
Cytometry. 2001 Aug 15;46(4):254-61. doi: 10.1002/cyto.1136.
Single-platform flow cytometric absolute cell counting protocols provide increased robustness for CD34+ cell enumeration by limiting potential sources of imprecision. However, samples with any cellular fragmentation or debris, such as cord blood samples, provide challenges for these assays. We describe a simple, robust absolute CD34+ cell counting protocol, suitable for cord blood, using TRUCOUNT absolute count tubes (BD Biosciences, San Jose, CA) and a modified ISHAGE (International Society for Hematotherapy and Graft Engineering) gating strategy. An advantage of TRUCOUNT tubes is that each tube is supplied with a known number of lyophilized fluorescent beads. The method includes no-wash fixative-free ammonium chloride red blood cell lysis and the viability dye, 7-amino actinomycin D, to exclude dead cells. The threshold was set on CD45 expression in the FL1 channel and an exclusion gate in the forward scatter channel reduced debris. No manual adjustment of the gating regions was required, even for samples in less than optimal condition. Comparison of the TRUCOUNT-ISHAGE protocol with the original dual-platform ISHAGE assay (n = 30) and the single-platform ISHAGE protocol using Flow-Count Fluorospheres (Beckman Coulter, Fullerton, CA; n = 22) showed high correlation (R(2) = 0.949 and 0.989, respectively) and no significant difference or bias for samples ranging from 22 to 600 CD34+ cells per microliter. Results are presented that demonstrate the detrimental effect of a fixative-containing lysis reagent when used in a lyse-and-wash procedure. The TRUCOUNT-ISHAGE protocol combines the attributes of TRUCOUNT tubes and the ISHAGE gating strategy to provide a single-platform protocol capable of achieving readily standardization of CD34+ cell enumeration.
单平台流式细胞术绝对细胞计数方案通过限制潜在的不精确来源,提高了CD34+细胞计数的稳健性。然而,含有任何细胞碎片或碎屑的样本,如脐带血样本,给这些检测带来了挑战。我们描述了一种简单、稳健的绝对CD34+细胞计数方案,适用于脐带血,该方案使用TRUCOUNT绝对计数管(BD生物科学公司,加利福尼亚州圣何塞)和改良的ISHAGE(国际血液治疗和移植工程学会)设门策略。TRUCOUNT管的一个优点是每个管都配有已知数量的冻干荧光微球。该方法包括无洗涤、无固定剂的氯化铵红细胞裂解和活性染料7-氨基放线菌素D,以排除死细胞。阈值设定在FL1通道中CD45的表达上,前向散射通道中的排除门减少了碎屑。即使对于条件不太理想的样本,也无需手动调整设门区域。将TRUCOUNT-ISHAGE方案与原始的双平台ISHAGE检测(n = 30)以及使用Flow-Count荧光微球的单平台ISHAGE方案(贝克曼库尔特公司,加利福尼亚州富勒顿;n = 22)进行比较,结果显示相关性很高(R(2)分别为0.949和0.989),对于每微升含有22至600个CD34+细胞的样本,没有显著差异或偏差。结果表明,含固定剂的裂解试剂在裂解和洗涤过程中使用时具有有害影响。TRUCOUNT-ISHAGE方案结合了TRUCOUNT管和ISHAGE设门策略的特点,提供了一种能够轻松实现CD34+细胞计数标准化的单平台方案。